Lineage Cell Therapeutics, Inc. (LCTX)
:LCTX
US Market

Lineage Therap (LCTX) Income Statement

Compare
1,945 Followers

Lineage Therap Income Statement

Last quarter (Q4 2024), Lineage Therap's total revenue was $2.87M, an increase of 37.36% from the same quarter last year. In Q4, Lineage Therap's net income was $-3.27M. See Lineage Therap’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.50M$ 8.95M$ 14.70M$ 3.90M$ 773.00K
Gross Profit
$ 9.16M$ 8.27M$ 13.97M$ 2.47M$ 388.00K
Operating Expenses
$ 30.64M$ 33.01M$ 36.49M$ 51.68M$ 26.84M
Depreciation and Amortization
$ 0.00$ 692.00K$ 727.00K$ 887.00K$ 2.11M
EBITDA
$ -21.48M$ -24.04M$ -21.79M$ -48.34M$ -24.41M
Operating Income
$ -21.48M$ -24.73M$ -22.52M$ -49.21M$ -26.45M
Other Income/Expenses
$ 2.90M$ 1.45M$ -3.29M$ 5.94M$ 4.52M
Pretax Income
$ -18.58M$ -23.28M$ -25.81M$ -43.27M$ -21.92M
Net Income
$ -18.61M$ -21.49M$ -26.35M$ -38.56M$ -20.68M
Per Share Metrics
Basic EPS
$ -0.09$ -0.12$ -0.16$ -0.23$ -0.14
Diluted EPS
$ -0.09$ -0.12$ -0.16$ -0.23$ -0.14
Weighted Average Shares Outstanding
200.19M 172.66M 169.79M 164.50M 150.04M
Weighted Average Shares Outstanding (Diluted)
200.19M 172.66M 169.79M 164.50M 150.04M
Currency in USD

Lineage Therap Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis